...
机译:胸腺素α1与癌症:对免疫效应子和肿瘤靶细胞的作用
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata,' Rome, Italy;
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier, 1-00133, Rome, Italy;
Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy;
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata,' Rome, Italy;
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata,' Rome, Italy;
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata,' Rome, Italy;
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata,' Rome, Italy;
Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy;
Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy;
Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata,' Rome, Italy;
thymosin α1; cancer; immune effector cells; tumor antigens;
机译:阶段2研究创新的立体定向体放射治疗部分肿瘤缺氧(SBRT-病态)克隆癌中的克隆致症中的克隆癌:通过施用Peri-tumoral免疫微环境进行深刻的非靶向效果
机译:阶段2研究创新的立体定向体放射治疗靶向骨骼缺氧(SBRT-病理)克隆癌中的临床缺氧(SBRT-病态)克隆癌:通过抑制围肿瘤免疫微环境的深刻非靶向效果
机译:靶向小分子抑制剂(cabozantinib)与癌症疫苗联合使用对免疫介导的杀伤肿瘤细胞和免疫肿瘤微环境的双重影响
机译:胸腺蛋白α1和癌症:免疫效应和肿瘤靶细胞的作用
机译:癌症相关的免疫缺陷和树突状细胞功能障碍:1.由前列腺素受体EP2介导。 2.髓样免疫抑制细胞在肿瘤与宿主之间的相互作用。
机译:针对无法切除的大块非小细胞肺癌中局部肿瘤缺氧(SBRT-PATHY)克隆细胞的创新立体定向放射疗法的单机构2期研究
机译:靶向小分子抑制剂(cabozantinib)与癌症疫苗联合使用对免疫介导的肿瘤细胞杀伤和免疫肿瘤微环境允许性的双重影响